1.lääketutkimuksen vaihe, jossa seurataan jo hyväksytyn lääkkeen vaikutuksia ja sitä voidaan kokeilla eri potilasryhmillä
1.sometimes the FDA approves a drug for general use but requires the manufacturer to continue to monitor its effects; during this phase the drug may be tried on slightly different patient populations than those studied in earlier trials